Skip to main content

Table 1 Primary criteria for study eligibility

From: Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: A randomized clinical trial protocol

Admission in ICU a due to TBI b

18 year ≤ age ≤ 65 year

GCS c score > 8

Stable hemodynamic and metabolic status in the first 24 to 48 h

Having enteral nutritional support

Fill out the informed consent form by the patient or first-degree relatives of the patient

  1. a Intensive care unit. b Traumatic brain injury. c Glasgow Coma Scale